Patents Represented by Attorney, Agent or Law Firm James P. Rick
  • Device housing for an aerosol container
    Patent number: 7661423
    Abstract: A housing for a mechanical or electrical device for use with an aerosol canister for containing chemical comprising a sleeve for receipt of the aerosol canister; a collar affixable around the neck of the canister; and a joint between the sleeve and the collar to secure the housing to the canister.
    Type: Grant
    Filed: February 26, 2003
    Date of Patent: February 16, 2010
    Assignee: GlaxoSmithKline LLC
    Inventors: Peter John Brand, James William Godfrey, Paul Kenneth Rand, Duncan Robertson
  • Anti-inflammatory androstane derivative
    Patent number: 7629335
    Abstract: According to one aspect of the invention, there is provided a compound of formula (I) and solvates thereof. There are also provided compositions containing the compound, processes for preparing it, and its use in therapy.
    Type: Grant
    Filed: July 6, 2006
    Date of Patent: December 8, 2009
    Assignee: Glaxo Group Limited
    Inventors: Keith Biggadike, Steven John Coote, Rosalyn Kay Nice
  • Morpholinyl-urea derivatives for use in the treatment of inflammatory diseases
    Patent number: 7622464
    Abstract: Compounds of formula (I): wherein: R1 represents substituted or unsubstituted heteroaryl; Y represents —(CRnaRnb)n—; Rna and Rnb are each independently hydrogen or C1-6alkyl; n is an integer from 0 to 5; R2 represents unsubstituted or substituted aryl or unsubstituted or substituted heteroaryl; R3 and R4 each independently represent hydrogen or C1-6-alkyl; R7 represents hydrogen or C1-6alkyl; R8 represents hydrogen or C1-6alkyl; and salts and solvates thereof; are CCR3 antagonists and are thus indicated to be useful in therapy.
    Type: Grant
    Filed: March 27, 2003
    Date of Patent: November 24, 2009
    Assignee: Glaxo Group Limited
    Inventors: Rachael Ann Ancliff, Caroline Mary Cook, Colin David Eldred, Paul Martin Gore, Lee Andrew Harrison, Martin Alistair Hayes, Simon Teanby Hodgson, Duncan Bruce Judd, Suzanne Elaine Keeling, Xiao Qing Lewell, Gail Mills, Graeme Michael Robertson, Stephen Swanson, Andrew John Walker, Mark Wilkinson
  • Formulation containing anti-inflammatory androstane derivative
    Patent number: 7541350
    Abstract: There is provided a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I) or a solvate thereof.
    Type: Grant
    Filed: August 13, 2004
    Date of Patent: June 2, 2009
    Assignee: Glaxo Group Limited
    Inventors: Keith Biggadike, Amyn Pyarali Sayani, Ian Richard Buxton, Kenton Lewis Reed
  • Dry powder inhaler
    Patent number: 6553987
    Abstract: A metering device suitable for use in a dry powder inhaler comprises a housing defining a reservoir. The reservoir contains a powder. A rotatable auger, having a first and second end, has one or more flutes extending between the ends. The first end of the auger communicates with the reservoir. A dosing member, defining a dosing recess having a desired volume, is positionable adjacent said second end of said auger. Rotation of said auger causes the powder to be transferred through the flutes and into the dosing recess to fill the recess volume with a specific dose of powder.
    Type: Grant
    Filed: August 23, 2001
    Date of Patent: April 29, 2003
    Assignee: SmithKline Beecham Corporation
    Inventor: Michael Birsha Davies
  • Label
    Patent number: D592252
    Type: Grant
    Filed: September 24, 2008
    Date of Patent: May 12, 2009
    Assignee: Glaxco Group Limited
    Inventors: Gary Thomas Crosby, David Vincent Elliman, Andrew Michael Kelly